鲁比前列酮结构式
|
常用名 | 鲁比前列酮 | 英文名 | Lubiprostone |
---|---|---|---|---|
CAS号 | 333963-40-9 | 分子量 | 390.462 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 532.3±50.0 °C at 760 mmHg | |
分子式 | C20H32F2O5 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 275.7±30.1 °C |
鲁比前列酮用途Lubiprostone, also known as RU-0211, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006. Lubiprostone is a bicyclic fatty acid derived from prostaglandin E1 that acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements (SBM). |
中文名 | 鲁比前列素 |
---|---|
英文名 | (2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-heptanoic acid |
中文别名 | (2R,4AR,5R,7AR)-2-(1,1-二氟戊基)-2-羟基-6-氧代-3,4,4A,5,7,7A-六氢环戊并[B]吡喃-5-庚酸 | 鲁比前列酮 | 卢比前列酮 |
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 532.3±50.0 °C at 760 mmHg |
分子式 | C20H32F2O5 |
分子量 | 390.462 |
闪点 | 275.7±30.1 °C |
精确质量 | 390.221771 |
PSA | 83.83000 |
LogP | 2.85 |
外观性状 | 固体 |
蒸汽压 | 0.0±3.2 mmHg at 25°C |
折射率 | 1.486 |
储存条件 | -20°C, 干燥 |
危害码 (欧洲) | Xn |
---|
鲁比前列酮上游产品 3 | |
---|---|
鲁比前列酮下游产品 0 |
(2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-h |
7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid |
Prostan-1-oic acid, 11,15-epoxy-16,16-difluoro-15-hydroxy-9-oxo-, (11α,15R)- |
Spi 0211 |
Lubiprostone |
Prostan-1-oic acid,11,15-epoxy-16,16-difluoro-15-hydroxy-9-oxo-,(11alpha,15R) |
(11α,15R)-16,16-Difluoro-15-hydroxy-9-oxo-11,15-epoxyprostan-1-oic acid |
7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yI]heptanoic acid |
[3H]-Lubiprostone |
Unii-7662kg2R6k |
(-)-7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid |